D.E. Shaw & Co Posiciones de la cartera
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Principales compras
| Clasificación | Acción | Valor |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+USD 9630 M |
| 2 |
Amazon
AMZN
|
+USD 1560 M |
| 3 |
NVIDIA
NVDA
|
+USD 1097 M |
| 4 |
Meta Platforms (Facebook)
META
|
+USD 924 M |
| 5 |
SpaceX
SPCX
|
+USD 907 M |
Principales ventas
| Clasificación | Acción | Valor |
|---|---|---|
| 1 |
Micron Technology
MU
|
+USD 2167 M |
| 2 |
Broadcom
AVGO
|
+USD 1526 M |
| 3 |
Microsoft
MSFT
|
+USD 1054 M |
| 4 |
TSMC
TSM
|
+USD 928 M |
| 5 |
Texas Instruments
TXN
|
+USD 904 M |
Composición por sector
| Clasificación | Sector | Peso |
|---|---|---|
| 1 | Varios | 33.7% |
| 2 | Tecnología | 18.77% |
| 3 | Finanzas | 8.35% |
| 4 | Salud | 7.91% |
| 5 | Consumo discrecional | 7.84% |
| Nombre | Valor de mercado | Peso en el portafolio | Acciones o capital principal |
Cambio en la participación | Flujo de capital | En cartera desde | |
|---|---|---|---|---|---|---|---|
4676
EUDA Health Holdings Warrant
EUDAW
| USD 6.94 k | ﹤0.01% |
200,000
| – | – |
2022 Q1
17 trimestres
|
|
4677
Apollomics Inc Warrant
APLMW
USD 975 k
| USD 6.37 k | ﹤0.01% |
318,530
| – | – |
2023 Q1
13 trimestres
|
|
4678
Baird Medical Investment Holdings Warrant
BDMDW
| USD 6.1 k | ﹤0.01% |
150,000
| – | – |
2024 Q4
6 trimestres
|
|
4679
Murano Global Investments PLC Warrants
MRNOW
USD 148 k
| USD 5.59 k | ﹤0.01% |
375,000
| – | – |
2024 Q1
9 trimestres
|
|
4680
Pagaya Technologies Ltd Warrants
PGYWW
USD 512 k
| USD 5.42 k | ﹤0.01% |
107,225
| – | – |
2022 Q2
16 trimestres
|
|
4681
Fusemachines Inc Warrants
FUSEW
USD 230 k
| USD 5.4 k | ﹤0.01% |
99,999
| – | – |
2025 Q4
2 trimestres
|
|
4682
Better Home & Finance Warrant
BETRW
USD 1.84 M
| USD 5.36 k | ﹤0.01% |
27,202
| – | – |
2021 Q2
20 trimestres
|
|
4683
Envoy Medical Warrant
COCHW
USD 550 k
| USD 5.1 k | ﹤0.01% |
113,431
| – | – |
2021 Q2
20 trimestres
|
|
4684
SHF Holdings Warrants
SHFSW
USD 159 k
| USD 5.06 k | ﹤0.01% |
188,000
| – | – |
2023 Q1
13 trimestres
|
|
|
VEEAW
4685
Veea Inc Warrant
VEEAW
| USD 4.63 k | ﹤0.01% |
90,749
| – | – |
2021 Q2
20 trimestres
|
|
4686
Zeo Energy Corp Warrants
ZEOWW
USD 154 k
| USD 4.5 k | ﹤0.01% |
125,000
| – | – |
2021 Q4
18 trimestres
|
|
|
CYCUW
4687
Cycurion Inc Warrant
CYCUW
USD 373 k
| USD 4.38 k | ﹤0.01% |
250,000
| – | – |
2022 Q2
16 trimestres
|
|
4688
Coincheck Group Warrant expiring 12/10/2029
CNCKW
| USD 4.37 k | ﹤0.01% |
21,831
| – | – |
2024 Q4
6 trimestres
|
|
4689
NET Power Inc Warrants
NPWR.WS
USD 6.17 M
| USD 4.36 k | ﹤0.01% |
15,032
| – | – |
2023 Q2
12 trimestres
|
|
4690
Dejó de cotizar
GDEV Inc Warrant
GDEVW
| USD 4.26 k | ﹤0.01% |
575,000
| – | – |
2021 Q3
19 trimestres
|
|
|
NIVFW
4691
NewGenIvf Group Warrants
NIVFW
| USD 4.22 k | ﹤0.01% |
168,750
| – | – |
2024 Q2
8 trimestres
|
|
4692
CDT Equity Inc Warrant
CDTTW
| USD 4.12 k | ﹤0.01% |
375,000
| – | – |
2022 Q2
16 trimestres
|
|
4693
Aspire-Lakewood Holdings, Inc. Warrant
ASBPW
| USD 4.1 k | ﹤0.01% |
199,999
| – | – |
2022 Q2
16 trimestres
|
|
4694
Psyence Biomedical Warrant
PBMWW
USD 210 k
| USD 3.68 k | ﹤0.01% |
175,352
| – | – |
2024 Q1
9 trimestres
|
|
4695
Able View Global Warrant
ABLVW
USD 108 k
| USD 3.28 k | ﹤0.01% |
200,000
| – | – |
2023 Q3
11 trimestres
|
|
4696
Scage Future Warrants
SCAGW
USD 196 k
| USD 3.05 k | ﹤0.01% |
68,749
| – | – |
2025 Q2
4 trimestres
|
|
|
LIMNW
4697
Liminatus Pharma Warrants
LIMNW
| USD 2.93 k | ﹤0.01% |
83,353
| – | – |
2025 Q2
4 trimestres
|
|
4698
Dejó de cotizar
Keen Vision Acquisition Corp Warrant
KVACW
| USD 2.91 k | ﹤0.01% |
97,000
| – | – |
2023 Q3
11 trimestres
|
|
4699
CID HoldCo Inc Warrants
DAICW
USD 133 k
| USD 2.48 k | ﹤0.01% |
199,999
| – | – |
2025 Q2
4 trimestres
|
|
4700
Southland Holdings Warrants
SLND.WS
USD 864 k
| USD 2.34 k | ﹤0.01% |
91,666
| – | – |
2021 Q4
18 trimestres
|
|
Fondos similares
Revisión del portafolio de D.E. Shaw & Co en T2 2026
Al cierre de T2 2026, D.E. Shaw & Co mantenía 5,360 posiciones por un valor de USD 210 mil M, un aumento de 26% frente a los USD 166 mil M del trimestre anterior. Sus diez principales posiciones representan 15% de la cartera.
D.E. Shaw & Co destinó USD 8308 M de nuevo capital neto durante T2 2026, abrió 872 nuevas posiciones y aumentó 1,718 posiciones existentes. Su mayor nueva posición fue SpaceX: 5,340,000 acciones con un valor de USD 912 M.
Por sector, la cartera tiene su mayor concentración en Varios, con 34% de los activos, frente a 30% un trimestre antes; le siguen Tecnología y Finanzas.
La mayor reducción de posición fue en Micron Technology, por un valor estimado de USD 2167 M.
- La mayor compra de D.E. Shaw & Co en T2 2026 fue SpaceX: 5,340,000 acciones por un valor de USD 912 M.
- D.E. Shaw & Co fue quien más aumentó su posición en State Street SPDR S&P 500 ETF Trust durante T2 2026, con un incremento estimado de USD 9630 M.
- La mayor reducción de D.E. Shaw & Co durante T2 2026 fue en Micron Technology, con un recorte estimado de USD 2167 M.
- D.E. Shaw & Co cerró por completo su posición en Automatic Data Processing en T2 2026, con una venta estimada de USD 241 M.
- Las diez principales posiciones de D.E. Shaw & Co representan 15% de su cartera de USD 210 mil M en T2 2026.
- D.E. Shaw & Co abrió 872 posiciones nuevas y cerró 527 en T2 2026.
- El valor de la cartera de D.E. Shaw & Co aumentó 26% respecto al trimestre anterior, hasta USD 210 mil M.
Según el Informe 13F de D.E. Shaw & Co correspondiente a T2 2026, presentado el 14 ago 2026.